In September 2017 a meeting was held with the main investigators of the TRANSBIO validation study and very positive feedback was received. The attendees were 7 renowned nephrologists of the following hospitals in Europe and USA:

  • Hospital Puerta de Hierro (Spain)
  • Hospital Vall d´Hebron (Spain)
  • Hospital del Mar (Spain)
  • Hospital La Paz (Spain)
  • Universitätsklinikum Essen (Germany)
  • Medical University Borowska (Poland)
  • University Hospital of Copenhagen (Denmark)
  • Massachusetts General Hospital, Harvard Medical School (Boston).

During the TTS 2018 congress presentation encouraging comments from several top KOL ( Charité Universitätsmedizin Berlin,  Germany; University Hospitals Leuven, Belgium; Necker Hospital in Paris, France) were received.

The TRANSBIO study results will be discussed in an investigator meeting during ESOT 2019